Importance of ileoscopy during colonoscopy for the early diagnosis of ileal tuberculosis: report of two cases.

Department of Medicine, Department of Pathology, Alice Ho Miu Ling Nethersole Hospital, Tai Po, New Territoties, Hong Kong SAR.
Gastrointestinal Endoscopy (Impact Factor: 4.9). 07/2001; 53(7):813-5. DOI: 10.1067/mge.2001.114954
Source: PubMed
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: During colonoscopy ileal intubation does not have a specific indication; neither is it accepted as a routine procedure.
    Revista Colombiana de Gastroenterologia 09/2008; 23(3):240-249.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gastrointestinal tuberculosis is defined as infection of the peritoneum, hollow or solid abdominal organs, and abdominal lymphatics with Mycobacterium tuberculosis organisms. Gastrointestinal tuberculosis is relatively rare in the United States and is the sixth most common extrapulmonary location. Populations at risk include immigrants to the United States, the homeless, prisoners, residents of long-term care facilities, and the immunocompromised. The peritoneum and the ileocecal region are the most likely sites of infection and are involved in the majority of cases by hematogenous spread or through swallowing of infected sputum from primary pulmonary tuberculosis. Pulmonary tuberculosis is apparent in less than half of patients. Patients usually present with abdominal pain, weight loss, fever, anorexia, change in bowel habits, nausea, and vomiting. The diagnosis is often delayed and is usually made through a combination of radiologic, endoscopic, microbiologic, histologic, and molecular techniques. Antimicrobial treatment is the same as for pulmonary tuberculosis. Surgery is occasionally required.
    Current Gastroenterology Reports 09/2003; 5(4):273-8. DOI:10.1007/s11894-003-0063-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the changing epidemiology of Crohn's disease (CD) and intestinal tuberculosis (ITB), we are in an era where the difficulty facing physicians in discriminating between the two diseases has increased, and the morbidity and mortality resulting from a delayed diagnosis or misdiagnosis is considerably high. In this article, we examine the changing trends in the epidemiology of CD and ITB, in addition to clinical features that aid in the differentiation of both diseases. The value of various laboratory, serological, and the tuberculin skin tests are reviewed as well. The use of an interferon-gamma-release assay, QuantiFERON-TB Gold, in the workup of these patients and its value in populations where the bacillus Calmette-Guérin vaccine is still administered is discussed. Different radiological, endoscopic, and pathological similarities and features that can aid the clinician in reaching a rapid diagnosis are reviewed as well. The association between mycobacteria and CD, the concerns with the practice of antituberculosis medication trials in areas where tuberculosis (TB) is endemic, as well as extrapulmonary TB induced by the use of antitumor necrosis factor-alpha agents are delineated in this article. Furthermore, we propose an algorithm for the investigation of patients in whom the differential diagnosis encompasses CD and ITB.
    The American Journal of Gastroenterology 03/2009; 104(4):1003-12. DOI:10.1038/ajg.2008.162 · 9.21 Impact Factor